Everolimus eluting bioresorbable vascular scaffolds; can we absorb the risk in complex PCI?

Firas Zahr; Joaquin E. Cigarroa

doi:10.1002/ccd.27165

Everolimus eluting bioresorbable vascular scaffolds; can we absorb the risk in complex PCI?

Firas Zahr, Joaquin E. Cigarroa

Knight Cardiovascular Institute

Research output: Contribution to journal › Editorial › peer-review

Abstract

BVS, as compared with DES, have higher stent thrombosis (ST) rates. BVS may prove reasonable in patients with complex anatomy. Future trials will be necessary to guide clinicians regarding whether BVS are equivalent to DES in patients with noncomplex or complex coronary anatomy.

Original language	English (US)
Pages (from-to)	70-71
Number of pages	2
Journal	Catheterization and Cardiovascular Interventions
Volume	90
Issue number	1
DOIs	https://doi.org/10.1002/ccd.27165
State	Published - Jul 1 2017

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1002/ccd.27165

Cite this

@article{e0fa9cdb7b694777a936798b65e9cbf8,

title = "Everolimus eluting bioresorbable vascular scaffolds; can we absorb the risk in complex PCI?",

abstract = "BVS, as compared with DES, have higher stent thrombosis (ST) rates. BVS may prove reasonable in patients with complex anatomy. Future trials will be necessary to guide clinicians regarding whether BVS are equivalent to DES in patients with noncomplex or complex coronary anatomy.",

author = "Firas Zahr and Cigarroa, {Joaquin E.}",

note = "Publisher Copyright: {\textcopyright} 2017 Wiley Periodicals, Inc.",

year = "2017",

month = jul,

day = "1",

doi = "10.1002/ccd.27165",

language = "English (US)",

volume = "90",

pages = "70--71",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",